New guidelines for severe respiratory infections

January 2004
CMAJ: Canadian Medical Association Journal;1/6/2004, Vol. 170 Issue 1, p26
Academic Journal
Reports on the effort of Health Canada to release new guidelines for handling severe respiratory infections in the SARS post-outbreak period, as of January 2004. Features of the new guidelines; Remarks from a critic of how SARS was handled.


Related Articles

  • RESPIRATORY TRACT.  // MPR - Long Term Care Edition;May2009, Vol. 4 Issue 1, p177 

    The article offers information on the different types of respiratory tract disorder and their respective treatment in the U.S. Asthma is common respiratory tract disorder and is a chronic inflammatory disorder of the airways. It states that inhaled corticosteroids such as beclomethasone,...

  • Antibiotic Prescribing for Cough and Symptoms of Respiratory Tract Infection: Do the Right Thing. Ebell, Mark H. // JAMA: Journal of the American Medical Association;6/22/2005, Vol. 293 Issue 24, p3062 

    Reports on the tendency of physicians to prescribe antibiotics to patients with cough and symptoms of respiratory tract infections. Details of a study conducted on patients with symptoms of respiratory tract infections; Lack of significant difference seen in treating cough with antibiotics...

  • Respiratory tract infections.  // Good Health (Australia Edition);Dec2015, p93 

    The article discusses several respiratory tract infections, their causes, complications, and treatments. Among the infections are pharyngitis, pneumonia, and tonsilitis. It claims that flu could worsen such medical conditions as asthma, diabetes, and heart problems. Also cited is when to decide...

  • Principles of Appropriate Antibiotic Use for Treatment of Nonspecific Upper Respiratory Tract Infections in Adults: Background. Gonzales, Ralph; Barlett, John G.; Besser, Richard E.; Hickner, John M.; Hoffman, Jerome R.; Sande, Merle A. // Annals of Internal Medicine;03/20/2001, Vol. 134 Issue 6, p490 

    Discusses the evidence-based recommendations of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Viral source of infection; Non-enhancement of illness resolution and is not recommended; Purulent secretions from the nares or throat predict...

  • Blocking TRPA1 in Respiratory Disorders: Does It Hold a Promise? Mukhopadhyay, Indranil; Kulkarni, Abhay; Khairatkar-Joshi, Neelima // Pharmaceuticals (14248247);Dec2016, Vol. 9 Issue 4, p1 

    Transient Receptor Potential Ankyrin 1 (TRPA1) ion channel is expressed abundantly on the C fibers that innervate almost entire respiratory tract starting from oral cavity and oropharynx, conducting airways in the trachea, bronchi, terminal bronchioles, respiratory bronchioles and upto alveolar...

  • Health Canada's Progressive Licensing Framework. Yeates, Neil; Lee, David K.; Maher, Maurica // CMAJ: Canadian Medical Association Journal;6/19/2007, Vol. 176 Issue 13, p1845 

    The article discusses the concepts governing the establishment of the new Progressive Licensing Framework, a new framework composing of laws, guidelines and regulations which will support the timely access to drugs and provide a mechanism for continuous reassessment and monitoring of a drug's...

  • Health Canada Announces Public Consultations on Proposed Health Legislation. Culbert, Ian // Canadian HIV/AIDS Policy & Law Review;Aug2003, Vol. 8 Issue 2, p29 

    Reports on public consultations on a proposed Canada Health Protection Act announced by Health Canada on June 9, 2003. Laws that will be replaced by the proposed legislation; Objective of the initiative; Documents that will be the basis of the consultations.

  • Access-to-information laws: they're there, if MDs want to use them. Rubin, Ken // CMAJ: Canadian Medical Association Journal;1/8/2002, Vol. 166 Issue 1, p77 

    Discusses federal policies in Canada relating to health care issues such as the use of marijuana for medical purposes. Information which physicians have access to regarding such issues; Mention of the Health Canada initiative; Advice on access-to-information legislation and record disclosure. ...

  • Fluoroquinolones are effective and well tolerated in the treatment of adults with lower respiratory tract infections.  // Drugs & Therapy Perspectives;May2006, Vol. 22 Issue 5, p15 

    The evolution of fluoroquinolones has seen a marked improvement in the bacterial coverage, tolerability and pharmacokinetics of members of this drug class. Clinical studies have demonstrated that fluoroquinolones are usually as effective as other recommended antibacterial regimens for treating...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics